Phase II trial of extended-dosing temozolomide in patients with melanomaPetra Rietschel, P. B. Chapman, Samuel Ejadi et al.|Journal of Clinical Oncology|2007Cited by 0
A phase II study of temozolomide (TMZ) and pegylated interferon α-2b (PGI) in the treatment of advanced melanomaSusan E. Krown, Jedd D. Wolchok, Lynne Lamb et al.|Journal of Clinical Oncology|2004Cited by 0